Quetiapin Ratiopharm 400 mg depottabletti Finlândia - finlandês - Fimea (Suomen lääkevirasto)

quetiapin ratiopharm 400 mg depottabletti

teva pharma b.v. - quetiapine fumarate - depottabletti - 400 mg - ketiapiini

ALBIOMIN 200 g/l infuusioneste, liuos Finlândia - finlandês - Fimea (Suomen lääkevirasto)

albiomin 200 g/l infuusioneste, liuos

biotest pharma gmbh - albuminum ihmisen - infuusioneste, liuos - 200 g/l - albumiini

Sutent União Europeia - finlandês - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinibi - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiset aineet - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Resolor União Europeia - finlandês - EMA (European Medicines Agency)

resolor

takeda pharmaceuticals international ag ireland - prucalopride succinate - ummetus - muut ummetuslääkkeet - resolor on tarkoitettu oireenmukaista hoitoa kroonisen ummetuksen aikuisilla, joille laksatiivit eivät tuo toivottua lievitystä.

Zyrtec 10 mg/ml tipat, liuos Finlândia - finlandês - Fimea (Suomen lääkevirasto)

zyrtec 10 mg/ml tipat, liuos

ucb pharma oy finland - cetirizine dihydrochloride - tipat, liuos - 10 mg/ml - setiritsiini

Vesicare 5 mg tabletti, kalvopäällysteinen Finlândia - finlandês - Fimea (Suomen lääkevirasto)

vesicare 5 mg tabletti, kalvopäällysteinen

astellas pharma a/s - solifenacin succinate - tabletti, kalvopäällysteinen - 5 mg - solifenasiini

Vesicare 10 mg tabletti, kalvopäällysteinen Finlândia - finlandês - Fimea (Suomen lääkevirasto)

vesicare 10 mg tabletti, kalvopäällysteinen

astellas pharma a/s - solifenacin succinate - tabletti, kalvopäällysteinen - 10 mg - solifenasiini

Upstaza União Europeia - finlandês - EMA (European Medicines Agency)

upstaza

ptc therapeutics international limited - eladocagene exuparvovec - aminohappoaineenvaihdunta, synnynnäiset virheet - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.

Elvanse 30 mg kapseli, kova Finlândia - finlandês - Fimea (Suomen lääkevirasto)

elvanse 30 mg kapseli, kova

takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 30 mg - lisdeksamfetamiini

Elvanse 50 mg kapseli, kova Finlândia - finlandês - Fimea (Suomen lääkevirasto)

elvanse 50 mg kapseli, kova

takeda pharmaceuticals international ag - lisdexamfetamine dimesylate - kapseli, kova - 50 mg - lisdeksamfetamiini